Clinical implication landmark: Noninvasive quantification of fractional flow reserve evaluating interventional therapy

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 2, 2014, Pages 334-335

  Qi, Xiaolong ^a   Fan, Guoxin ^a   Zhou, Lin ^a   Yang, Changqing ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD; FRACTIONAL FLOW RESERVE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LETTER; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RADIOLUCENT BIORESORBABLE VASCULAR SCAFFOLDING DEVICE; ULTRASOUND; VASCULAR EQUIPMENT;

ABSORBABLE IMPLANTS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL REVASCULARIZATION; SIROLIMUS;

EID: 84892804208     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25195     Document Type: Letter

References (5)

1. Nieman K, Serruys PW, Onuma Y, et al. Multislice computed tomography angiography for non-invasive assessment of the 18-months performance of a novel radiolucent bioresorbable vascular scaffolding device (ABSORB Trial). J Am Coll Cardiol 2013; pii: S0735-S1097.
2. Koo BK, Erglis A, Doh JH, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol 2011; 58: 1989-1997.
3. Min JK, Leipsic J, Pencina MJ, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 2012; 308: 1237-1245.
4. Taylor CA, Fonte TA, Min JK,. Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: Scientific basis. J Am Coll Cardiol 2013; 61: 2233-2241.
5. Ormiston JA, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet 2008; 371: 899-907.